Chemical Genetics Hits "Reality"
- 1 October 2004
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 306 (5693) , 67-68
- https://doi.org/10.1126/science.1104611
Abstract
Forward chemical genetic screening is analogous to the classical genetics strategy of mutagenesis, except that a small molecule takes the place of a genetic mutation in altering the function of one or more gene products. In their Perspective, Bellows and Tyers discuss an elegant forward chemical genetic screen that identifies small-molecule inhibitors called ubistatins that disrupt the cell's protein degradation machinery ( Verma et al.). This work is an excellent example of the systematic identification of small-molecule inhibitors of complex biological processes and the characterization of their molecular targets.Keywords
This publication has 13 references indexed in Scilit:
- Ubistatins Inhibit Proteasome-Dependent Degradation by Binding the Ubiquitin ChainScience, 2004
- Multiubiquitin Chain Receptors Define a Layer of Substrate Selectivity in the Ubiquitin-Proteasome SystemCell, 2004
- Genetic and Genomic Approaches to Identify and Study the Targets of Bioactive Small MoleculesChemistry & Biology, 2004
- Chemogenomics: an emerging strategy for rapid target and drug discoveryNature Reviews Genetics, 2004
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- From large networks to small moleculesCurrent Opinion in Chemical Biology, 2003
- Assembly of Cell Regulatory Systems Through Protein Interaction DomainsScience, 2003
- The Anaphase-Promoting ComplexMolecular Cell, 2002
- THE UBIQUITIN SYSTEMAnnual Review of Biochemistry, 1998
- How Proteolysis Drives the Cell CycleScience, 1996